Vectibix and Oxycontin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vectibix (panitumumab) and Oxycontin (oxycodone hydrochloride). Common drug interactions include febrile neutropenia among females and decreased appetite among males.

The phase IV clinical study analyzes what interactions people have when they take Vectibix and Oxycontin. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Vectibix?

Vectibix has active ingredients of panitumumab. eHealthMe is studying from 8,945 Vectibix users. Check the latest studies of Vectibix.

What is Oxycontin?

Oxycontin has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 212,533 Oxycontin users. Check the latest studies of Oxycontin.

On Aug, 09, 2026

29 people who take Vectibix and Oxycontin together, and have interactions are studied.

Vectibix and Oxycontin drug interactions.

What are the common drug interactions of Vectibix and Oxycontin, by gender? *:

female:

Febrile neutropenia (fever with reduced white blood cells)
Abdominal discomfort
Abdominal pain
Anxiety
Blood potassium decreased
General physical health deterioration (weak health status)
Hyperhidrosis (abnormally increased sweating)
Muscle spasms (muscle contraction)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

male:

Decreased appetite
Abdominal pain
Tension (the act or process of stretching something tight)
Loss of consciousness
Arrhythmia (irregular heartbeat)
Ascites (accumulation of fluid in the abdominal cavity)
Blood magnesium decreased
Cardiac failure
Diarrhoea
Disease progression

What are the common drug interactions of Vectibix and Oxycontin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Abdominal pain
Anxiety
Blood potassium decreased
General physical health deterioration (weak health status)
Hyperhidrosis (abnormally increased sweating)
Muscle spasms (muscle contraction)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Infusion related reaction
Hypophagia (reduced food intake)
Malaise (a feeling of general discomfort or uneasiness)

50-59:

Abdominal pain
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Febrile neutropenia (fever with reduced white blood cells)
Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
Hyperammonaemia
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Platelet count decreased
Pneumonia
Renal tubular disorder (disease of kidney tubules)
Sepsis (a severe blood infection that can lead to organ failure and death)

60+:

Febrile neutropenia (fever with reduced white blood cells)
Abdominal discomfort
Chest pain
Chills (felling of cold)
Disinhibition (loss of inhibition)
Dysphoria (generalized dissatisfaction with life)
Leukopenia (less number of white blood cells in blood)
Nausea (feeling of having an urge to vomit)
Stress cardiomyopathy (stress-induced chronic disease of the heart muscle)
Tension (the act or process of stretching something tight)

What are the existing conditions these people have? *

Colon Cancer: 16 people, 55.17%
Rectal Cancer (cancer of rectum): 4 people, 13.79%
Rectal Cancer Recurrent (reoccurrence of rectum cancer): 3 people, 10.34%
Insomnia (sleeplessness): 2 people, 6.90%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 6.90%
High Blood Pressure: 2 people, 6.90%
Constipation: 2 people, 6.90%
Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 2 people, 6.90%
Cancer Pain: 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Vectibix and Oxycontin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously